Our combination of practice excellence and deep industry expertise provides a distinct competitive advantage to our clients, bringing together legal expertise, commercial insight and close professional support.
Law-Now Zones provide expert analysis on specialist topics
Join the CMS Life Sciences & Healthcare Sector Group for their annual Webinar Spring Series between April-June.
In this guide, we have taken a look back at the top 10 developments of 2017 and also looked ahead to 2018 with our top 10 predictions for you and your business operating in China.
For analysis and commentary on the impact of Brexit on businesses operating in, and trading with, the UK
Patents Without Borders is the home of the CMS international patent law practice online, including our cross-border patent litigation team
Welcome to the home of lifesciences – regulation on Law-Now.
On this page, you will find all the articles and publications for lifesciences regulation.
To stay in touch with the latest developments, please bookmark this page on your mobile or register to receive eAlerts.
In a recent executive meeting of the State Council, the Premier, Li Keqiang, confirmed the strategy of developing “Internet +” medical and healthcare services...
The General Court decided in its decision of 14 March 2018 that non-governmental organizations (“NGOs”) can ask the Commission to review its decision on...
From 1 April 2018, a new duty of candour applies to health, care and social work organisations in Scotland, requiring them to inform people (or their families)...
The CFDA further cracking down on food safety issues, 21 March
The China Food and Drug Administration (“CFDA”) announced that it will take serious measures...
You may be reflecting on what your business can expect to face this year, both in terms of opportunities and challenges in China, particularly as 2017...
2016 saw important legal news and developments in the Lifesciences sector in China and we have produced the ‘China Lifesciences Update and Predictions...
We are delighted to attach the Autumn 2016 edition of The Antidote, our Lifesciences sector bulletin.
In this edition, we look at:
A recent report...
The British people have voted to leave the European Union.
No European Union Member State has left the EU so the process of withdrawal is untested. Effecting...
There have been no recent searches
Login to manage your preferences now
Analysis and commentary
What are the legal issues for the lifesciences sector following a Brexit? Read CMS’ Lifesciences checklist to help guide you through what a Brexit could really mean for your business
© CMS Legal 2018